ArticleHeliyon2022

Dichloroacetate, a pyruvate dehydrogenase kinase inhibitor, ameliorates type 2 diabetes via reduced gluconeogenesis.

Yuko Katayama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.